Takeda Pharmaceutical Income Statement
View: Annual | Quarterly
| Mar 08 | Mar 07+ | Dec 06+ | |
|---|---|---|---|
| Revenue | 13,845.6 | 11,073.0 | 10,177.7 |
| Cost of Goods Sold | 2,806.1 | 2,372.7 | -- |
| Gross Profit | 11,039.5 | 8,700.4 | -- |
| Gross Profit Margin | 79.7% | 78.6% | 0.0% |
| SG&A Expense | 6,778.3 | 4,810.5 | -- |
| Depreciation & Amortization | 319.1 | 244.5 | -- |
| Operating Income | 5,812.7 | 5,307.8 | -- |
| Operating Margin | 42.0% | 47.9% | -- |
| Nonoperating Income | 967.9 | 940.7 | -- |
| Nonoperating Expenses | 621.7 | 475.1 | -- |
| Income Before Taxes | 5,809.4 | 5,305.7 | -- |
| Income Taxes | 2,203.2 | 2,425.1 | -- |
| Net Income After Taxes | 3,606.2 | 2,880.6 | 0.0 |
| Continuing Operations | 3,579.8 | 2,849.0 | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 3,579.8 | 2,849.0 | -- |
| Total Net Income | 3,579.8 | 2,849.0 | 2,630.0 |
| Net Profit Margin | 25.9% | 25.7% | 25.8% |
| Diluted EPS from Total Net Income ($) | 4.22 | 3.27 | -- |
| Dividends per Share | 0.00 | 0.00 | -- |
© 2009 Morningstar, Inc. Financial Data provided by
